Logo-bi
Original Research
Farideh Pak, Alireza Farajollahi*, Alireza Naseri, Ali Movafaghi
Bioimpacts. 2013;3(4): 163-168. doi: 10.5681/bi.2013.019
PMCID: PMC3892735     PMID: 24455479     Scopus ID: 84893357831    
PDF
XML
Cited By:
Original Research
Roghaye Khodadadi, Azim Khajeali, Alireza Farajollahi*, Parisa Hajalioghli, Noorallah Raeisi
Bioimpacts. 2015;5(3): 129-133. doi: 10.15171/bi.2015.16
PMCID: PMC4597160     PMID: 26457250     Scopus ID: 84944407994    
PDF
XML
Cited By:
Original Research
Tatiana Matvienko, Viktoriya Sokolova, Svitlana Prylutska, Yuliia Harahuts, Nataliya Kutsevol, Viktor Kostjukov, Maxim Evstigneev* ORCID, Yuriy Prylutskyy*, Matthias Epple, Uwe Ritter
Bioimpacts. 2019;9(1): 57-63. doi: 10.15171/bi.2019.07
PMCID: PMC6378100     PMID: 30788260     Scopus ID: 85060451771    
It was found that the Dextran-PNIPAM+Dox nanofluid in contrast to Dox alone showed higher toxicity towards HeLa cells, whereas the SWCNT+Dox and GO+Dox nanofluids protected cells from Dox.


As a peer-reviewed international open-access journal, BioImpacts publishes articles on basic and translational aspects of pharmaceutical and biomedical sciences. 
Acceptance rate: 24% 
Publication fee: Free of charge